Brave Warrior Capital Ups Passive Stake In VistaPrint Limited (VPRT) To Over 10%


In an amended filing, Brave Warrior Capital, managed by Glenn Greenberg, has disclosed upping its stake in VistaPrint Limited (NASDAQ:VPRT). Brave Warrior Capital currently owns 3.35 million shares of the company, up from 3.19 million shares held previously. The stake is passive by nature and represents 10.07% of the company’s common stock.

Glenn Greenberg

VistaPrint Limited (NASDAQ:VPRT) is a provider of a wide range of customized printing, graphic design and marketing products and services to micro businesses and consumers. The company employs globally more than 4,600 people, operates over 25 websites globally and ships to more than 130 countries around the world.

Last month, VistaPrint Limited (NASDAQ:VPRT) announced that it is opening its first office in the United Kingdom this summer in order to get closer to customers and support growth in its largest EU market. The site, located in Kings Cross, London, will house an expanded UK Country Team responsible for marketing the company’s range of affordable and professional products and services that support micro business owners and consumers across the UK, according to a statement.

VistaPrint Limited (NASDAQ:VPRT) has a market cap of $1.4 billion and trails a P/E ratio of 31.56. On the company’s stock, analysts have a consensus average target price of $46.13 and a consensus average recommendation is Hold. Currently, the company’s shares trade at $41.12.

Other significant shareholders of VistaPrint Limited (NASDAQ:VPRT) include Scott Mclellan’s Marble Arch Investments and Edward Goodnow’s Goodnow Investment Group, owning 861,000 shares and 534,779 shares, respectively.

Brave Warrior focuses on value investing for institutions and individuals. The value of the fund’s equity portfolio was $2.44 billion as of the end of 2013. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was represented as the largest holding, in which the fund owned 6.11 million shares. It is followed by Express Scripts Holding Company (NASDAQ:ESRX), in which the fund held 3.96 million shares.

Disclosure: none